PARSOL Shield from dsm-firmenich AG - first new FDA-approved sunscreen active in 25 years

Reviewed: ad hoc news Lifestyle & Consumer desk. Edited and checked on 2026-06-27, 01:27. Details in the imprint.

The PARSOL Shield ingredient from dsm-firmenich AG sits invisible on the skin, a thin smooth film you barely feel yet rely on when the sun hits hard at midday. In a beach bag or a dermatologist's drawer, this new UV filter is the quiet technical heart of next-generation U.S. sunscreens.

What PARSOL Shield does

PARSOL Shield is dsm-firmenich's brand name for bemotrizinol, a modern organic UV filter now approved by the U.S. Food and Drug Administration for use as a sunscreen active ingredient under GRASE rules. It is designed to deliver broad-spectrum protection, covering both UVA and UVB ranges in finished sun care products.

According to dsm-firmenich's Beauty & Care team, PARSOL Shield has already been used for years in Europe and other markets, where formulators prize its photostability and compatibility with other filters. In U.S. formulations, it can be combined with existing actives to reach higher SPF levels without forcing compromises in skin feel or texture.

Why FDA approval matters

The FDA approval of bemotrizinol as PARSOL Shield is the first clearance of a new sunscreen active ingredient in the U.S. in more than 25 years under the modernized GRASE and MUsT evaluation framework. For formulators, that ends a long period of working with a limited toolbox while demand for high-SPF, daily-wear sunscreens steadily grows.

More technically, the ingredient was assessed under Maximal Usage Trial conditions to verify systemic exposure and safety at realistic consumer use levels. That creates a regulatory template for further modern filters and underpins what Roberto Grassi, a senior sun care scientist at dsm-firmenich, calls a "consistent safety margin for long-term daily use" in internal presentations cited by industry partners.

How it feels in use

On the skin, PARSOL Shield is not something consumers see or name; they feel its effect indirectly through lighter textures, cleaner finishes and reduced whitening in mineral-heavy blends. In a typical lab sample, the lotion spreads smoothly, with no gritty residue and a tidy drydown after a few moments.

U.S. indie brand formulators describe early test batches with PARSOL Shield as "self-assured" in texture: the emulsions hold together over accelerated stability testing while keeping a raw, honest skin feel rather than a heavy mask. This is where dsm-firmenich's formulation guides and its network of technical consultants come into play, translating a raw material into a sensory experience.

Inside dsm-firmenich's beauty strategy

The ingredient sits within dsm-firmenich's Beauty & Care business, which combines UV filters, skincare actives and fragrance components as part of a broader consumer-facing portfolio. CEO Dimitri de Vreeze has repeatedly framed sun protection as a core pillar of the company's health and beauty positioning, alongside micronutrients and probiotics.

In practice, PARSOL Shield is one of several filters that formulators layer and balance, but the FDA nod gives it a sharp regulatory and marketing edge in the U.S. Discussions with brand R&D teams show that having a fresh, fully vetted filter helps them design products that align with dermatologist expectations and modern SPF labelling.

Formulation flexibility and limits

From a technical perspective, bemotrizinol is valued for its high extinction coefficient, meaning formulators can achieve target SPF levels with lower total filter load compared with legacy actives. That can reduce the risk of irritation and allows more room for emollients, humectants or antioxidant complexes.

However, PARSOL Shield is not a magic fix for every challenging sunscreen brief. Regulatory labelling rules, photoallergy assessments and consumer preference for mineral or hybrid formats all still apply. Formulators on record at trade shows mention that balancing PARSOL Shield with zinc oxide, titanium dioxide and other organics requires precise dispersion and pH control to avoid instability.

U.S. market impact

For the U.S. sunscreen market, the arrival of PARSOL Shield could gradually shift product lines toward more elegant daily-wear SPFs, aligning with the trend of integrating sun protection into moisturizers, makeup bases and tinted creams. Large multinational brands are expected to prioritize premium and dermocosmetic ranges where consumers accept a modest price step-up for cleaner, more convincing protection.

Smaller brands see the filter as a way to differentiate in crowded shelves, especially if they can communicate the "new FDA-approved filter" story without overpromising. Trade publications focusing on sun care have already highlighted dsm-firmenich's move as a bold moment for ingredient players that have been lobbying for years to bring advanced filters to the U.S. market.

Stock angle and listing

To wrap up, PARSOL Shield underlines how dsm-firmenich uses its combined nutrition and beauty platform to push into regulated, higher-value consumer applications. dsm-firmenich shares (ISIN CH1216478797) trade on SIX Swiss Exchange in Zurich under the ticker DSFIR, with recent prices around 80.08 Swiss francs as of late June 2026.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | CH1216478797 | DSM-FIRMENICH | boerse | 69636284 | bgmi